77
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a Phase II, randomized study

, , , , , , , , , , , & show all
Pages 611-617 | Published online: 23 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Rola El Sayed & Haidar El Darsa. (2022) Therapeutic modalities in small cell lung cancer: a paradigm shift after decades of quiescence. Expert Opinion on Pharmacotherapy 23:5, pages 583-597.
Read now
Lizza E. L. Hendriks, Jessica Menis & Martin Reck. (2019) Prospects of targeted and immune therapies in SCLC. Expert Review of Anticancer Therapy 19:2, pages 151-167.
Read now
Xiao-Zheng He, Qi-Fu Wang, Shuai Han, Hui-Qing Wang, Yong-Yi Ye, Zhi-Yuan Zhu & Shi-Zhong Zhang. (2015) Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes. Drug Design, Development and Therapy 9, pages 1449-1458.
Read now
Erika Vacchelli, Fernando Aranda, Florine Obrist, Alexander Eggermont, Jérôme Galon, Isabelle Cremer, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial watch. OncoImmunology 3:6.
Read now
Konstantinos Zarogoulidis, Efimia Boutsikou, Paul Zarogoulidis, Kaid Darwiche, Lutz Freitag, Konstantinos Porpodis, Dimitrios Latsios, Theodoros Kontakiotis, Haidong Huang, Qiang Li, Wolfgang Hohenforst-Schmidt, Maria Kipourou, J Francis Turner & Dionysios Spyratos. (2013) The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis. OncoTargets and Therapy 6, pages 1493-1500.
Read now

Articles from other publishers (18)

Yan Lin, Xiaoli Liao, Yumei Zhang, Guobin Wu, Jiazhou Ye, Shanshan Luo, Xinxin He, Min Luo, Mingzhi Xie, Jinyan Zhang, Qian Li, Yu Huang, Sina Liao, Yongqiang Li & Rong Liang. (2022) Homologous Recombination Pathway Alternation Predicts Prognosis of Colorectal Cancer With Chemotherapy. Frontiers in Pharmacology 13.
Crossref
皓悦 王. (2022) Research on Targeting and Immunotherapy of Small Cell Lung Cancer. Advances in Clinical Medicine 12:08, pages 7005-7011.
Crossref
Tomonari Kinoshita, Hideki Terai & Tomonori Yaguchi. (2021) Clinical Efficacy and Future Prospects of Immunotherapy in Lung Cancer. Life 11:10, pages 1029.
Crossref
Andreas Saltos, Michael Shafique & Alberto Chiappori. (2020) Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC). Frontiers in Oncology 10.
Crossref
Ioanna Tsiouprou, Athanasios Zaharias & Dionisios Spyratos. (2019) The Role of Immunotherapy in Extensive Stage Small-Cell Lung Cancer: A Review of the Literature. Canadian Respiratory Journal 2019, pages 1-7.
Crossref
Lum & Alamgeer. (2019) Technological and Therapeutic Advances in Advanced Small Cell Lung Cancer. Cancers 11:10, pages 1570.
Crossref
Thomas G. Johnson, Karin Schelch, Sunali Mehta, Andrew Burgess & Glen Reid. (2019) Why Be One Protein When You Can Affect Many? The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma. Frontiers in Cell and Developmental Biology 7.
Crossref
A. Calles, G. Aguado, C. Sandoval & R. Álvarez. (2019) The role of immunotherapy in small cell lung cancer. Clinical and Translational Oncology 21:8, pages 961-976.
Crossref
Fang Peng, Qiang Li, Shao-Qing Niu, Guo-Ping Shen, Ying Luo, Ming Chen & Yong Bao. (2019) ZWINT is the next potential target for lung cancer therapy. Journal of Cancer Research and Clinical Oncology 145:3, pages 661-673.
Crossref
Chen Ni, Pan Ma, Liwei Qu, Fan Wu, Junfeng Hao, Ruirui Wang, Yu Lu, Wei Yang, Ulrike Erben & Zhihai Qin. (2017) Accelerated tumour metastasis due to interferon-γ receptor-mediated dissociation of perivascular cells from blood vessels. The Journal of Pathology 242:3, pages 334-346.
Crossref
Alfredo Tartarone, Pasqualina Giordano, Rosa Lerose, Maria Grazia Rodriquenz, Raffaele Conca & Michele Aieta. (2017) Progress and challenges in the treatment of small cell lung cancer. Medical Oncology 34:6.
Crossref
Leora Horn, Martin Reck & David R. Spigel. (2016) The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer. The Oncologist 21:8, pages 910-921.
Crossref
Martin Reck, David Heigener & Niels Reinmuth. (2016) Immunotherapy for small-cell lung cancer: emerging evidence. Future Oncology 12:7, pages 931-943.
Crossref
Erica B. Bernhardt & Shadia I. Jalal. 2016. Lung Cancer. Lung Cancer 301 322 .
Ronald D. Alvarez, Michael W. Sill, Susan A. Davidson, Carolyn Y. Muller, David P. Bender, Robert L. DeBernardo, Kian Behbakht & Warner K. Huh. (2014) A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG–PEI–cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group study. Gynecologic Oncology 133:3, pages 433-438.
Crossref
Yuling Zhang, Hongzheng Ren, Lu Wang, Zhifeng Ning, Yixuan Zhuang, Jinfeng Gan, Shaobin Chen, David Zhou, Hua Zhu, Dongfeng Tan & Hao Zhang. (2014) Clinical Impact of Tumor-Infiltrating Inflammatory Cells in Primary Small Cell Esophageal Carcinoma. International Journal of Molecular Sciences 15:6, pages 9718-9734.
Crossref
A Baliaka, P Zarogoulidis, K Domvri, W Hohenforst-Schmidt, A Sakkas, H Huang, P Le Pivert, G Koliakos, E Koliakou, K Kouzi-koliakos, K Tsakiridis, A Chioti, E Siotou, A Cheva, K Zarogoulidis & L Sakkas. (2013) Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with 2-Diethylaminoethyl-Dextran Methyl Methacrylate Copolymer Non-Viral Vector–p53. Gene Therapy 21:2, pages 158-167.
Crossref
Matthew Whitehurst & Alberto Chiappori. (2013) Immunotherapy treatments for small-cell lung cancer: past, present and future. Lung Cancer Management 2:6, pages 517-525.
Crossref